We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
President Trump signed Congress’ combined appropriations and COVID-19 relief package late on Sunday, averting a looming federal government shutdown. Read More
Swedish drugmaker Vicore Pharma has reported positive results from a phase 2 study evaluating its oral therapy for treating respiratory infection in hospitalized COVID-19 patients. Read More
Merck has signed a contract to supply up to 100,000 doses of its experimental COVID-19 treatment, MK-7110, to the U.S. government for $356 million, provided the investigational biologic earns the FDA’s approval or Emergency Use Authorization. Read More
The U.S. and Pfizer have agreed to another vaccine supply deal that will net the government an additional 100 million doses of Pfizer/BioNTech’s coronavirus vaccine in summer 2021. Read More
The National Institutes of Health (NIH) has paused enrollment of critically ill COVID-19 patients in a phase 3 trial of various blood thinners, one of three international trials evaluating whether a full or lower dose of anticoagulants in hospitalized COVID-19 patients is more effective. Read More
Malvern, Pa.-based biotech Ocugen and India’s Bharat Biotech have agreed to work together to develop the Indian company’s COVID-19 vaccine for use in the U.S., a product that is already far along in clinical trials. Read More
Vaccine makers are currently evaluating if a new, highly contagious COVID-19 strain identified in the UK could slip past their shots, but Pfizer/BioNTech, Moderna and others are confident their vaccines will protect against the new mutation, which is likely already in the U.S. Read More
CanSino Biologics has enrolled more than 20,000 participants in a global phase 3 study of its COVID-19 vaccine candidate, Ad5-nCoV, co-developed with a research arm of the Chinese military. Read More
The House Select Subcommittee on the Coronavirus Crisis issued subpoenas on Monday to the chiefs of HHS and the Centers for Disease Control and Prevention (CDC), demanding documents relating to the Democrats’ investigation of alleged political tampering with coronavirus response efforts. Read More
Vaccinations using Pfizer/BioNTech’s COVID-19 vaccine are set to begin Sunday throughout Europe, following the European Commission’s landmark authorization of its first coronavirus vaccine. Read More